6 not yet recruiting. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Not yet recruiting 6 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease MHB018A injection - Thyroid Eye Disease (TED) | Phase 3 | Not yet recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 219 | 2027-07-01 | 2026-06-04 |
| An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease BHV-1300 - Graves' Disease | Phase 2 / Phase 3 | Not yet recruiting | Biohaven Therapeutics Ltd. | 356 | 2026-10-01 | 2026-10-28 |
| A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid Eye Disease KHN939, Placebo - Thyroid Eye Disease | Phase 3 | Not yet recruiting | Beijing Kanghong Biological Medicine Co., Ltd. | 60 | 2026-08-01 | 2026-07-23 |
| A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease KHN939, Placebo - Thyroid Eye Disease | Phase 3 | Not yet recruiting | Beijing Kanghong Biological Medicine Co., Ltd. | 117 | 2026-08-01 | 2026-07-23 |
| Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC desiccated thyroid extract (DTE)+levothyroxine (L-T4) - Intermediate-to-High Risk Differentiated Thyroid Cancer | Phase 3 | Not yet recruiting | West China Hospital | 646 | 2025-11-30 | 2025-11-20 |
| A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study Atorvastatin 20mg, Placebo - Graves' Orbitopathy | Phase 3 | Not yet recruiting | University of Pisa | 102 | 2024-01-01 | 2023-03-15 |
Graves Ophthalmopathy (4) · Graves Disease (1) · Hyperthyroidism (1)
Endocrine System Diseases (6) · Autoimmune Diseases (5) · Exophthalmos (5) · Eye Diseases (5) · Goiter (5) · Immune System Diseases (5) · Orbital Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Eye Diseases, Hereditary (4) · Genetic Diseases, Inborn (4) · Graves Disease (4) · Hyperthyroidism (4)
Atorvastatin (1) · Thyroid (USP) (1) · Thyroxine (1)
Beijing Kanghong Biological Medicine Co., Ltd. (2) · Biohaven Therapeutics Ltd. (1) · Minghui Pharmaceutical (Hangzhou) Ltd (1) · University of Pisa (1) · West China Hospital (1)
China (2) · Italy (1)
PMID 28960722, PMID 33178770, PMID 33662333, PMID 34302730, PMID 34670546, PMID 34935859, PMID 35639050, PMID 37668013, PMID 40844370